Ionis Pharmaceuticals, Inc. <IONS.O>: Barclays cuts target price to $85 from $90
IONS•Related News
Trisalus Life Sciences, Inc. <TLSI.O>: H.C. Wainwright Initiates Coverage With Buy Rating and Target Price $11
TLSI•
Zomedica to host “Fourth Friday at Four” investor webinar on marketing-led demand generation
ZOM•
KBR wins three-year US government contract for radio frequency engineering work
KBR•
Bank of Montreal becomes first Big Five bank to eliminate most online trading commissions
BMO•
Collegium Pharmaceutical, Inc. <COLL.O>: Leerink Partners initiates coverage with outperform rating; price target $45
COLL•